MedPath

遂成药业股份有限公司

Ownership
-
Established
1997-10-17
Employees
-
Market Cap
-
Website
www.scyygs.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

201

NMPA:201

Drug Approvals

Famotidine Injection

Product Name
法莫替丁注射液
Approval Number
国药准字H20258089
Approval Date
May 23, 2025
NMPA

Procaterol Hydrochloride Oral Solution

Product Name
盐酸丙卡特罗口服溶液
Approval Number
国药准字H20253924
Approval Date
Apr 15, 2025
NMPA

Procaterol Hydrochloride Oral Solution

Product Name
盐酸丙卡特罗口服溶液
Approval Number
国药准字H20253923
Approval Date
Apr 15, 2025
NMPA

Oseltamivir Phosphate for Suspension

Product Name
磷酸奥司他韦干混悬剂
Approval Number
国药准字H20253902
Approval Date
Apr 15, 2025
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20253780
Approval Date
Apr 1, 2025
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20253779
Approval Date
Apr 1, 2025
NMPA

Dopamine Hydrochloride Injection

Product Name
盐酸多巴胺注射液
Approval Number
国药准字H20253681
Approval Date
Mar 25, 2025
NMPA

Dopamine Hydrochloride Injection

Product Name
盐酸多巴胺注射液
Approval Number
国药准字H20253682
Approval Date
Mar 25, 2025
NMPA

Adenosine Injection

Product Name
腺苷注射液
Approval Number
国药准字H20253494
Approval Date
Mar 4, 2025
NMPA

Adenosine Injection

Product Name
腺苷注射液
Approval Number
国药准字H20253495
Approval Date
Mar 4, 2025
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.